Stock News - MetaVia Inc. $MTVA
Latest Stock News for $MTVA
MetaVia Inc. Updates Corporate Presentation, Highlights Growth Opportunities in Cardiometabolic Diseases
Expected Stock impact: Slightly Positive
2026-03-26 20:33:30
MetaVia Inc. Reports Year-End 2025 Financial Results with Positive Phase 1 Data for DA-1726
Expected Stock impact: Noticeably Positive
2026-03-26 12:32:34
MetaVia Inc. Receives IRB Approval for Phase 1 Clinical Trial of DA-1726, a Dual Agonist for Obesity Treatment
Expected Stock impact: Very Positive
2026-03-18 12:07:13
